Bone Marrow-derived Mesenchymal Stem Cells Reverse Hepatic Fibrosis, Improved Vascularity, and Attenuate the Apoptosis in Carbon Tetrachloride-induced Hepatic Fibrosis Experimental Rats

Zainab Altaib; Walaa S. Sabbah; Eman K. Rashwan; Ashraf Albrakati; Abeer Mostafa

doi:10.3889/oamjms.2021.6590

Authors

Zainab Altaib Department of Histology and Cell Biology, Faculty of Medicine, Helwan University, Helwan, Egypt
Walaa S. Sabbah Department of Anatomy
Eman K. Rashwan Department of Physiology, College of Medicine, Jouf University, Sakaka, Saudi Arabia
Ashraf Albrakati Department of Human Anatomy, College of Medicine, Taif University, Taif, Saudi Arabia https://orcid.org/0000-0002-4116-7865
Abeer Mostafa Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt https://orcid.org/0000-0002-3034-3835

DOI:

https://doi.org/10.3889/oamjms.2021.6590

Keywords:

Mesenchymal stem cells, Liver fibrosis, Inflammatory cytokines and vascular endothelial growth factor

Abstract

Background: Liver fibrosis is a sequel of different chronic inflammatory diseases. The most effective treatment for end-stage liver fibrosis is liver transplantation; but the shortage of donor organs, immunological rejection, surgical complications, and high medical costs limit the transplantation. That’s why we are in argent need to develop new strategies in treatment. Objectives: to evaluate the role of MSCs in regenerating liver cells and reverse hepatic fibrosis. Materials and Methods: 30 Animals were randomly divided into three groups (10 animals each): group 1: a negative control; group 2: induced liver fibrosis (pathological control).; group 3: induced liver fibrosis that received undifferentiated BM MSCs (3×106 cells/ml intraperitoneally/single dose); The extent of fibrosis, vascularization, and inflammation and hepatic cell apoptosis were evaluated together with assessment of liver functions. Results: The MSCs treated group showed significant improvement of liver functions, and attenuation of fibrosis histopathologicaly and down regulate the expression of TGF ß versus the induced fibrosis group. inflammatory marker(TNF,IL-6) were down regulated and vascularity was restored in MSCs treated group compared to CCL4 induced fibrosis rats. Conclusion: MSCs provide promising therapeutic agents in treatment of liver fibrosis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Weiskirchen R, Weiskirchen S, Tacke F. Recent advances in understanding liver fibrosis: Bridging basic science and individualized treatment concepts. F1000Res. 2018;7:921. https://doi.org/10.12688/f1000research.14841.1 PMid:30002817

Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: Concept to treatment. J Hepatol. 2015;62(1):S15-24. https://doi.org/10.1016/j.jhep.2015.02.039 PMid:25920084

Eom YW, Shim KY, Baik SK. Mesenchymal stem cell therapy for liver fibrosis. Korean J Intern Med. 2015;30(5):580-9. https://doi.org/10.3904/kjim.2015.30.5.580 PMid:26354051

Usunier B, Benderitter M, Tamarat R, Chapel A. Management of fibrosis: The mesenchymal stromal cells breakthrough. Stem Cells Int. 2014;2014:340257. https://doi.org/10.1155/2014/340257 PMid:25132856

Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun. 2007;363:247-52. https://doi.org/10.1016/j.bbrc.2007.05.150 PMid:17869217

Chen S, Xu L, Lin N, Pan W, Hu K, Xu R. Activation of Notch1 signaling by marrow-derived mesenchymal stem cells through cell-cell contact inhibits proliferation of hepatic stellate cells. Life Sci. 2011;89(25-26):975-81. https://doi.org/10.1016/j.lfs.2011.10.012 PMid:22056375

Wu T, Li J, Li Y, Song H. Antioxidant and hepatoprotective effect of swertiamarin on carbon tetrachloride-induced hepatotoxicity via the Nrf2/HO-1 pathway. Cell Physiol Biochem. 2017;41(6):2242-54. https://doi.org/10.1159/000475639 PMid:28448964

Farouk S, Sabet S, Abu Zahra FA, El-Ghor AA. Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis. PLoS One. 2018;13(10):e0206130. https://doi.org/10.1371/journal.pone.0206130 PMid:30346985

Suvarna SK, Layton C, Bancroft JD, editors. Bancroft’s Theory and Practice of Histological Techniques. 7th ed. Philadelphia, PA: Churchill Livingstone; 2013. https://doi.org/10.1016/b978-0-7020-6864-5.05001-5

Gebler A, Zabel O, Seliger B. The immunomodulatory capacity of mesenchymal stem cells. Trends Mol Med. 2012;18(2):128-34. https://doi.org/10.1016/j.molmed.2011.10.004 PMid:22118960

Fu X, Li H. Mesenchymal stem cells and skin wound repair and regeneration: Possibilities and questions. Cell Tissue Res. 2009;335(2):317-21. https://doi.org/10.1007/s00441-008-0724-3 PMid:19034523

Geerts AM, Vanheule E, Praet M, Van Vlierberghe H, De Vos M, Colle I. Comparison of three research models of portal hypertension in mice: Macroscopic, histological and portal pressure evaluation. Int J Exp Pathol. 2008;89(4):251-63. https://doi.org/10.1111/j.1365-2613.2008.00597.x PMid:18715470

Cheung PY, Zhang Q, Zhang YO, Bai GR, Lin MC, Chan B, et al. Effect of WeiJia on carbon tetrachloride induced chronic liver injury. World J Gastroenterol. 2006;12(12):1912-7. https://doi.org/10.3748/wjg.v12.i12.1912 PMid:16609998

Senoo H, Yoshikawa K, Morii M, Miura M, Imai K, Mezaki Y. Hepatic stellate cell (Vitamin A-storing cell) and its relative-- past, present and future. Cell Biol Int. 2010;34(12):1247-72. https://doi.org/10.1042/cbi20100321 PMid:21067523

Jung YJ, Ryu KH, Cho SJ, Woo SY, Seoh JY, Chun CH, et al. Syngenic bone marrow cells restore hepatic function in carbon tetrachloride-induced mouse liver injury. Stem Cells Dev. 2006;15(5):687-95. https://doi.org/10.1089/scd.2006.15.687 PMid:17105404

Bauer M, Schuppan D. TGFbeta1 in liver fibrosis: Time to change paradigms? FEBS Lett. 2001;502:1-3. PMid:11478937

Yang FR, Fang BW, Lou JS. Effects of Haobie Yangyin Ruanjian decoction on hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol. 2010;16(12):1458-64. https://doi.org/10.3748/wjg.v16.i12.1458 PMid:20333785

Xu YQ, Liu ZC. Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches. Stem Cell Rev. 2008;4(2):101-12. https://doi.org/10.1007/s12015-008-9019-z PMid:18481229

Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol. 2006;44(4):742-8. https://doi.org/10.1016/j.jhep.2005.10.026 PMid:16469408

Ali G, Masoud MS. Bone marrow cells ameliorate liver fibrosis and express albumin after transplantation in CCl4-induced fibrotic iver. Saudi J Gastroenterol. 2012;18(4):263-7. https://doi.org/10.4103/1319-3767.98433 PMid:22824770

Dai LJ, Li HY, Guan LX, Ritchie G, Zhou JX. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res. 2009;2(1):16-25. https://doi.org/10.1016/j.scr.2008.07.005 PMid:19383405

Shao CH, Chen SL, Dong TF, Chai H, Yu Y, Deng L, et al. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats. J Surg Res. 2014;186(1):408-16. https://doi.org/10.1016/j.jss.2013.08.016 PMid:24071025

Wei C, Chen J, Liu J. Ultrastructure study of hepatocellular carcinoma treated by diamminedichloroplatinum. Zhonghua Gan Zang Bing Za Zhi. 2000;8(2):89-90. PMid:10861112

Youle RJ, Strasser A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47-59. https://doi.org/10.1038/nrm2308 PMid:18097445

Choi I, Kang HS, Yang Y, Pyun KH. IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clin Exp Immunol. 1994;95(3):530-5. https://doi.org/10.1111/j.1365-2249.1994.tb07031.x PMid:8137551

Prystupa A, Kiciński P, Sak J, Boguszewska-Czubara A, Toruń- Jurkowska A, Załuska W. Proinflammatory cytokines (IL-1α, IL-6) and hepatocyte growth factor in patients with alcoholic liver cirrhosis. Gastroenterol Res Pract. 2015;2015:532615. https://doi.org/10.1155/2015/532615 PMid:26448742

Mourtzikoua A, Alepakia M, Stamoulic M, Pouliakisa A, Sklirisc A, Karakitsos P. Effect of umbilical cord mesenchymal stem cell transplantation on immune function and prognosis of patients with decompensated hepatitis B cirrhosis. Inmunologia. 2014;33(1):41-50.

Fang XQ, Zhang JF, Song HY, Chen ZL, Dong J, Chen X, et al. Effect of umbilical cord mesenchymal stem cell transplantation on immune function and prognosis of patients with decompensated hepatitis B cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2016;24(12):907-10. https://doi.org/10.1111/jgh.14081 PMid:28073411

Sabry D, Mohamed A, Monir M, Ibrahim HA. The effect of mesenchymal stem cells derived microvesicles on the treatment of experimental CCL4 induced liver fibrosis in rats. Int J Stem Cells. 2019;12(3):400-9. https://doi.org/10.15283/ijsc18143 PMid:31474025

Truong NH, Nguyen NH, Van Le T, Vu NB, Huynh N, Van Nguyen T, et al. Comparison of the treatment efficiency of bone marrow-derived mesenchymal stem cell transplantation via tail and portal veins in CCl4-induced mouse liver fibrosis. Stem Cells Int. 2016;2016:5720413. https://doi.org/10.1155/2016/5720413